PRECISION BIOLOGICS, INC.

Patent Applications and Registrations

Patent applications and USPTO patent grants for PRECISION BIOLOGICS, INC..The latest application filed is for "colon and pancreas cancer peptidomimetics".

Company Profile

11.34.21

PRECISION BIOLOGICS, INC. - Bethesda MD US
PRECISION BIOLOGICS, INC. - Rockville MD US
Precision Biologics, Inc. - Dallas TX

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancers Grant 11,401,341 - Bristol , et al. August 2, 2	2022-08-02
Colon and pancreas cancer specific antigens and antibodies Grant 11,345,733 - Du , et al. May 31, 2	2022-05-31
Anti-cancer antibodies, combination therapies, and uses thereof Grant 11,279,768 - Arlen March 22, 2	2022-03-22
Colon and Pancreas Cancer Peptidomimetics App 20210395321 - WANG; Xue-Ping	2021-12-23
Colon and pancreas cancer peptidomimetics Grant 11,078,245 - Wang August 3, 2	2021-08-03
Monoclonal antibody therapy for pancreas cancer Grant 11,001,641 - Arlen , et al. May 11, 2	2021-05-11
Humanized Monoclonal Antibodies And Methods Of Use For The Diagnosis And Treatment Of Colon And Pancreas Cancer App 20210002368 - WANG; Xue-Ping ; et al.	2021-01-07
Methods And Compositions For Targeting Treg Cells App 20210002383 - ARLEN; Philip M. ; et al.	2021-01-07
Monoclonal Antibody Neo-201 For The Treatment Of Human Carcinomas App 20200362053 - ARLEN; Philip M. ; et al.	2020-11-19
Recombinant Monoclonal Antibodies And Corresponding Antigens For Colon And Pancreatic Cancers App 20200255535 - Kind Code	2020-08-13
Humanized monoclonal antibodies and methods of use for the diagnosis and treatment of colon and pancreas cancer Grant 10,689,443 - Wang , et al.	2020-06-23
Colon and Pancreas Cancer Peptidomimetics App 20200165310 - WANG; Xue-Ping	2020-05-28
Colon and pancreas cancer peptidomimetics Grant 10,533,040 - Wang Ja	2020-01-14
Colon And Pancreas Cancer Specific Antigens And Antibodies App 20190322720 - DU; Xiulian ; et al.	2019-10-24
Recombinant Monoclonal Antibodies And Corresponding Antigens For Colon And Pancreatic Cancers App 20190322759 - ARLEN; Myron ; et al.	2019-10-24
Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancers Grant 10,364,295 - Arlen , et al.	2019-07-30
Monoclonal Antibody Therapy For Pancreas Cancer App 20190100601 - Arlen; Myron ; et al.	2019-04-04
Recombinant Monoclonal Antibodies And Corresponding Antigens For Colon And Pancreatic Cancers App 20180346594 - BRISTOL; J. ANDREW ; et al.	2018-12-06
Humanized Monoclonal Antibodies And Methods Of Use For The Diagnosis And Treatment Of Colon And Pancreas Cancer App 20180265583 - WANG; Xue-Ping ; et al.	2018-09-20
Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancers Grant 10,023,650 - Bristol , et al. July 17, 2	2018-07-17
Humanized monoclonal antibodies and methods of use for the diagnosis and treatment of colon and pancreas cancer Grant 9,938,344 - Wang , et al. April 10, 2	2018-04-10
Colon And Pancreas Cancer Peptidomimetics App 20170362288 - WANG; Xue-Ping	2017-12-21
Recombinant Monoclonal Antibodies And Corresponding Antigens For Colon And Pancreatic Cancers App 20170218080 - ARLEN; Myron ; et al.	2017-08-03
Colon and pancreas cancer peptidomimetics Grant 9,718,866 - Wang August 1, 2	2017-08-01
Monoclonal Antibody Therapy For Pancreas Cancer App 20170210816 - ARLEN; MYRON ; et al.	2017-07-27
Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancers Grant 9,605,077 - Arlen , et al. March 28, 2	2017-03-28
Monoclonal antibody therapy for pancreas cancer Grant 9,592,290 - Arlen , et al. March 14, 2	2017-03-14
Recombinant Monoclonal Antibodies And Corresponding Antigens For Colon And Pancreatic Cancers App 20160326260 - BRISTOL; J. Andrew ; et al.	2016-11-10
Humanized Monoclonal Antibodies and Methods of Use for the Diagnosis and Treatment of Colon and Pancreas Cancer App 20160194398 - WANG; Xue-Ping ; et al.	2016-07-07
Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancers Grant 9,371,375 - Bristol , et al. June 21, 2	2016-06-21
Recombinant Monoclonal Antibodies And Corresponding Antigens For Colon And Pancreatic Cancers App 20150353644 - Arlen; Myron ; et al.	2015-12-10
Colon and Pancreas Cancer Peptidomimetics App 20150337023 - Wang; Xue-Ping	2015-11-26
Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancers Grant 9,169,326 - Arlen , et al. October 27, 2	2015-10-27
Colon and pancreas cancer peptidomimetics Grant 9,068,014 - Wang June 30, 2	2015-06-30
Monoclonal antibody therapy for pancreas cancer Grant 9,034,588 - Arlen , et al. May 19, 2	2015-05-19
Monoclonal Antibody Therapy For Pancreas Cancer App 20150104464 - Arlen; Myron ; et al.	2015-04-16
Recombinant Monoclonal Antibodies And Corresponding Antigens For Colon And Pancreatic Cancers App 20140369926 - BRISTOL; J. Andrew ; et al.	2014-12-18
Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancers Grant 8,802,090 - Bristol , et al. August 12, 2	2014-08-12
Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancers Grant 8,535,667 - Arlen , et al. September 17, 2	2013-09-17
Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancers Grant 8,524,456 - Bristol , et al. September 3, 2	2013-09-03
Colon And Pancreas Cancer Specific Antigens And Antibodies App 20130189268 - Du; Xiulian ; et al.	2013-07-25

Company Registrations

NCAGE Code	6VCM9	PRECISION BIOLOGICS, INC.
CAGE Code	6VCM9	PRECISION BIOLOGICS, INC.
SEC	0001560075	Precision Biologics, Inc. of DELAWARE

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.